Aisling Capital Management LP Bridge Bio Pharma, Inc. Transaction History
Aisling Capital Management LP
- $273 Million
- Q4 2024
A detailed history of Aisling Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 6,068,125 shares of BBIO stock, worth $212 Million. This represents 61.0% of its overall portfolio holdings.
Number of Shares
6,068,125
Previous 6,068,125
-0.0%
Holding current value
$212 Million
Previous $154 Million
7.78%
% of portfolio
61.0%
Previous 63.58%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$883 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$878 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$527 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$435 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$216 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.18B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...